PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Eureka invests in healthcare comms firm

Eureka Equity Partners has recapitalised Blueprint NYC a healthcare communications agency providing promotional services to pharmaceutical manufacturers and biotech companies, in partnership with the firm’s founders and senior team leaders.

Eureka Equity Partners (Eureka) has recapitalised Blueprint NYC (Blueprint) a healthcare communications agency providing promotional services to pharmaceutical manufacturers and biotech companies, in partnership with the firm’s founders and senior team leaders.

Financial details of the transaction have not been disclosed. Eureka  targets niche market leading firms with up to $100 million in revenue.
  
Founded in New York in 2021, Blueprint provides meeting and event production, training, experiential marketing, and strategic communications services, with a focus on clients’ sales & marketing teams to support the commercialisation and marketing of pharmaceutical products.
      
Webster Bank provided debt facilities to support the acquisition, and Fairmount Partners provided investment banking advisory services to Blueprint to facilitate the transaction.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured